The table below shows ACADIA PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$1.07B
$957.80M
$726.44M
$517.24M
$484.14M
$441.75M
Cost of revenue
$89.00M
$81.84M
$41.64M
$10.17M
$19.14M
$10.21M
Gross profit
-
-
$684.80M
$507.07M
$473.30M
$431.54M
R&D
$328.80M
$303.25M
$351.62M
$361.57M
$239.41M
$319.13M
ACAD annual revenue (10-K history)
ACADIA PHARMACEUTICALS INC reported annual revenue of $1.07B for fiscal year 2025. That is up 11.9% from $957.80M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $17.33M (FY 2016) to $1.07B. Figures come from the company's audited annual reports as filed with the SEC.
